EBITDA CAGR uses clean operating EBITDA derived from reported operating income plus depreciation and amortization.
Over longer horizons, EBITDA CAGR averages 4.50% over 3 years and 3.39% over 5 years; the trailing 12 months came in at +5.29%. EBITDA CAGR shows how the company's operating profitability has grown before depreciation and amortization. This reflects the growth of the core business's cash-operating earnings power, independent of capital-intensity and accounting depreciation choices.
Cigna Corporation (CI)
EBITDA growth vs the same quarter one year earlier, last 40 quarters.
Reported quarterly EBITDA; no daily interpolation.
| Year | Start EBITDA | End EBITDA | Change | % Change |
|---|---|---|---|---|
| 2025 | $11.17B | $11.76B | +$591.00M | +5.29% |
| 2024 | $10.35B | $11.17B | +$823.00M | +7.95% |
| 2023 | $10.31B | $10.35B | +$41.00M | +0.40% |
| 2022 | $9.74B | $10.31B | +$565.00M | +5.80% |
| 2021 | $9.96B | $9.74B | −$214.00M | -2.15% |
| 2020 | $10.84B | $9.96B | −$888.00M | -8.19% |
| 2019 | $4.52B | $10.84B | +$6.33B | +140.12% |
| 2018 | $4.19B | $4.52B | +$324.00M | +7.73% |
| 2017 | $3.38B | $4.19B | +$817.00M | +24.21% |
| 2016 | $12.66B | $3.38B | −$9.29B | -73.35% |
| 2015 | $11.90B | $12.66B | +$758.00M | +6.37% |
| 2014 | $32.98B | $11.90B | −$21.07B | -63.90% |
| 2013 | $3.44B | $32.98B | +$29.54B | +860.03% |
| 2012 | $2.22B | $3.44B | +$1.21B | +54.66% |
| 2011 | $2.09B | $2.22B | +$127.00M | +6.06% |
| 2010 | $2.17B | $2.09B | −$72.00M | -3.32% |
| 2009 | $626.00M | $2.17B | +$1.54B | +246.01% |
| 2008 | $1.82B | $626.00M | −$1.20B | -65.70% |
| 2007 | $1.94B | $1.82B | −$114.00M | -5.88% |
| 2006 | $2.01B | $1.94B | −$75.00M | -3.72% |
| 2005 | $2.60B | $2.01B | −$591.00M | -22.69% |
| 2004 | $1.15B | $2.60B | +$1.46B | +126.72% |
| 2003 | $1.22B | $1.15B | −$75.00M | -6.13% |
| 2001 | $1.72B | $1.22B | −$494.00M | -28.75% |
| 2000 | $1.44B | $1.72B | +$274.00M | +18.98% |
| 1999 | $2.08B | $1.44B | −$632.00M | -30.44% |
| 1998 | $1.60B | $2.08B | +$475.00M | +29.67% |
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Quarter ended Jun 2026 | $3.33B | +10.7% | +7.0% |
| Quarter ended Mar 2026 | $3.01B | +10.3% | +13.7% |
| Quarter ended Dec 2025 | $2.73B | -16.7% | -3.2% |
| Quarter ended Sep 2025 | $3.27B | +5.2% | +1.5% |
| Quarter ended Jun 2025 | $3.11B | +17.7% | -1.1% |
| Quarter ended Mar 2025 | $2.65B | -6.2% | -11.7% |
| Quarter ended Dec 2024 | $2.82B | -12.6% | -0.2% |
| Quarter ended Sep 2024 | $3.23B | +2.4% | +7.3% |
| Quarter ended Jun 2024 | $3.15B | +5.1% | +5.8% |
| Quarter ended Mar 2024 | $3.00B | +6.1% | +8.4% |
| Quarter ended Dec 2023 | $2.83B | -6.0% | +13.7% |
| Quarter ended Sep 2023 | $3.01B | +1.0% | +4.8% |
| Quarter ended Jun 2023 | $2.98B | +7.7% | -4.9% |
| Quarter ended Mar 2023 | $2.76B | +11.3% | -4.9% |
| Quarter ended Dec 2022 | $2.48B | -13.4% | +8.9% |
| Quarter ended Sep 2022 | $2.87B | -8.4% | -5.3% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
